Stay updated on Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” It appears above the unavailable study record and does not provide study-specific information.
    Difference
    1%
    Check dated 2026-10-24T13:10:56.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2; the study record page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T14:07:30.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-10T14:13:51.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a minimal header and a Home button. This replaces the previously visible study record content and related information on the page.
    Difference
    20%
    Check dated 2026-09-19T19:05:42.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.5 to v3.6.6, reflecting an incremental update to the page’s content/template managed by the site. This change signals a maintenance update and does not modify the study data or key details presented on the page.
    Difference
    0.1%
    Check dated 2026-08-29T19:16:41.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    The page now displays a new revision tag, v3.6.5, replacing the previous v3.6.4 revision tag.
    Difference
    0.0%
    Check dated 2026-08-08T17:02:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.